Pharmacokinetic comparison of six anthelmintics in sheep, goats, and cattle

• Published in: Journal of veterinary pharmacology and therapeutics Vol. 44; no. 1; pp. 58 - 67
• Main Authors: Myers, Michael J., Howard, Karyn D., Kawalek, Joseph C.
• Format: Journal Article
• Language: English
• Published: England 01-01-2021
• Subjects: anthelmintics; pharmacokinetics; ruminants; pharmacokinetics; ruminants; anthelmintics
• ISSN: 0140-7783; 1365-2885
• DOI: 10.1111/jvp.12897

This study was initiated to determine whether a comparative pharmacokinetic (PK) approach could be used to expand the pool of approved anthelmintics for minor ruminant species. Accordingly, the PK profiles of six anthelmintics (levamisole, albendazole, fenbendazole, moxidectin, doramectin, and ivermectin) in sheep, goats, and cattle were determined. The PK values determined for each anthelmintic included Tmax, Tlast, Cmax, AUC, AUC/dose, and Cmax/dose. The results of this study demonstrate that a comparative PK approach does not show commonality in the way these six anthelmintics are individually processed by these three ruminants. While some drugs demonstrated identical PK profiles between sheep and goats, none of these drugs demonstrated PK profiles in sheep and goats comparable to the PK profiles found in cattle. The results from this study suggest drug approval across these three ruminants is not a viable concept. However, the resulting PK profiles for each combination of drug and ruminant species represents a new dataset that can be used to support the US FDA Center for Veterinary Medicine's Minor Use/Minor Species indexing process for drug approvals in minor species such as sheep and goats.